Information Library

Results for: Cost control/reduction - Flexible outsourcing - Consulting - Product Development & Commercialization

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Outsourcing as strategic alternative to your own headcount

    Presentation — May 25, 2010
    Approach of Roche Italy in outsourcing their primary care sales force to Quintiles

  • Focused Co-Promotion

    Case Study — May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • The Power of Consolidation: How to Gain Efficiencies without Sacrificing Quality

    Case Study — March 31, 2010
    Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management.

  • Geoff Garabedian

    Hear from the Experts — March 25, 2009
    As Practice Leader for Regulatory and Quality in the U.S., Geoff combines a strong management consulting background with specific experience in the regulatory and compliance arena, including design and implementation of large-scale process, organization and technology transformations.

  • Jim Featherstone, Ph.D.

    Hear from the Experts — March 25, 2009
    Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

  • Podcast: A New Gold Standard

    Hear from the Experts — May 1, 2008
    John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences